EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

QSAR Modeling for Predicting Beta-Secretase 1 Inhibitory Activity in Alzheimer's Disease with Support Vector Regression

Teuku Rizky Noviandy, Ghifari Maulana Idroes, Trina Ekawati Tallei, Dian Handayani, Rinaldi Idroes

Malacca Pharmaceutics · 2024

DOI: 10.60084/mp.v2i2.226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malacca Pharmaceutics, 2024. Verfasst von Teuku Rizky Noviandy und 4 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive decline, with the accumulation of β-amyloid (Aβ) plaques playing a key role in its progression. Beta-Secretase 1 (BACE1) is a crucial enzyme in Aβ production, making it a prime therapeutic target for AD treatment. However, designing effective BACE1 inhibitors has been challenging due to poor selectivity and limited blood-brain barrier permeability. To address these challenges, we employed a machine learning approach using Support Vector Regression (SVR) in a Quantitative Structure-Activity Relationship (QSAR) model to predict the inhibitory activity of potential BACE1 inhibitors. Our model, trained on a dataset of 7,298 compounds from the ChEMBL database, accurately predicted pIC50 values using molecular descriptors, achieving an R² of 0.690 on the testing set. The model's performance demonstrates its utility in prioritizing drug candidates, potentially accelerating drug discovery. This study highlights the effectiveness of computational approaches in optimizing drug discovery and suggests that further refinement could enhance the model’s predictive power for AD therapeutics.

Zitieren

APA

Noviandy, T. R., Idroes, G. M., Tallei, T. E., Handayani, D., & Idroes, R. (2024). QSAR Modeling for Predicting Beta-Secretase 1 Inhibitory Activity in Alzheimer's Disease with Support Vector Regression. Malacca Pharmaceutics. https://doi.org/10.60084/mp.v2i2.226

Vancouver

Noviandy TR, Idroes GM, Tallei TE, Handayani D, Idroes R. QSAR Modeling for Predicting Beta-Secretase 1 Inhibitory Activity in Alzheimer's Disease with Support Vector Regression. Malacca Pharmaceutics. 2024. doi:10.60084/mp.v2i2.226

BibTeX
@article{Noviandy2024,
  author = {Noviandy, Teuku Rizky and Idroes, Ghifari Maulana and Tallei, Trina Ekawati and Handayani, Dian and Idroes, Rinaldi},
  title = {QSAR Modeling for Predicting Beta-Secretase 1 Inhibitory Activity in Alzheimer's Disease with Support Vector Regression},
  journal = {Malacca Pharmaceutics},
  year = {2024},
  doi = {10.60084/mp.v2i2.226}
}
Kostenlos starten →